Breast ductal carcinoma in situ (DCIS): Reproductive and hormonal risk factors and reliability of histologic diagnoses

作者: Lynette S. Phillips

DOI:

关键词:

摘要: Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous disease with no single histopathologic classification system. It unclear which features pathologists use to categorize DCIS clinical practice, and consistency categorization among unknown. Five from separate North Carolina hospitals rated 53 slides on overall (comedo or non-comedo type DCIS), pattern necrosis (central/comedo-type, punctate/individual cell, absent) maximum nuclear diameter determine inter-observer reliability using kappa (κ) statistic. Agreement diagnosis was moderate (κ=0.48, 95% CI=0.41-0.55), while fair for (κ=0.35, CI=0.30-0.41) (κ=0.22, CI=0.16-0.28). These results indicate inconsistency add growing evidence that universal system needed ensure accurate, reliable diagnoses. Introduction As U.S. incidence rates ductal have increased increase mammographic screening early 1980s, struggled define disease. are malignant tumors confined lactiferous ducts, without stromal invasion across basement

参考文章(101)
Rilke F, Feudale E, Riva C, Foschini Mp, Conti A, Micheli A, Eusebi, Di Palma S, Long-term follow-up of in situ carcinoma of the breast. Seminars in Diagnostic Pathology. ,vol. 11, pp. 223- 235 ,(1994)
V Eusebi, B Zafrani, J L Peterse, R Holland, D Faverly, R R Millis, M J van de Vijver, Ductal carcinoma in situ: a proposal for a new classification. Seminars in Diagnostic Pathology. ,vol. 11, pp. 167- 180 ,(1994)
R W Blamey, I O Ellis, C W Elston, M J Silverstein, D N Poller, A P Locker, M Galea, Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Modern Pathology. ,vol. 7, pp. 257- 262 ,(1994)
G.M. Mariuzzi, L. Mariuzzi, A. Mombello, A. Santinelli, M. Valli, D. Rahal, D. Thompson, P.H. Bartels, Quantitative study of ductal breast cancer progression. Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions. Pathology Research and Practice. ,vol. 190, pp. 1056- 1065 ,(1994) , 10.1016/S0344-0338(11)80901-5
Michael D. Lagios, Duct Carcinoma in Situ: Pathology and Treatment Surgical Clinics of North America. ,vol. 70, pp. 853- 871 ,(1990) , 10.1016/S0039-6109(16)45185-6
Henry F. Frierson, Robert A. Wolber, Kenneth W. Berean, Douglas W. Franquemont, Michael J. Gaffey, James C. Boyd, David C. Wilbur, Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. American Journal of Clinical Pathology. ,vol. 103, pp. 195- 198 ,(1995) , 10.1093/AJCP/103.2.195
J Z Thomson, A J Evans, S E Pinder, H C Burrell, A R M Wilson, I O Ellis, Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings. British Journal of Cancer. ,vol. 85, pp. 225- 227 ,(2001) , 10.1054/BJOC.2001.1877
Isabelle de Mascarel, Gaëtan MacGrogan, Simone Mathoulin-Pélissier, Isabelle Soubeyran, Véronique Picot, Jean-Michel Coindre, Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer. ,vol. 94, pp. 2134- 2142 ,(2002) , 10.1002/CNCR.10451
Jose Russo, Raquel Moral, Gabriela A Balogh, Daniel Mailo, Irma H Russo, The protective role of pregnancy in breast cancer Breast Cancer Research. ,vol. 7, pp. 131- 142 ,(2005) , 10.1186/BCR1029
Malcolm C. Pike, Darcy V. Spicer, Laila Dahmoush, Michael F. Press, Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk Epidemiologic Reviews. ,vol. 15, pp. 17- 35 ,(1993) , 10.1093/OXFORDJOURNALS.EPIREV.A036102